Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Talecris Biotherapeutics Holdings Corp. | a10-1548_110k.htm |
| EX-21 - EX-21 - Talecris Biotherapeutics Holdings Corp. | a10-1548_1ex21.htm |
| EX-32.2 - EX-32.2 - Talecris Biotherapeutics Holdings Corp. | a10-1548_1ex32d2.htm |
| EX-32.1 - EX-32.1 - Talecris Biotherapeutics Holdings Corp. | a10-1548_1ex32d1.htm |
| EX-31.2 - EX-31.2 - Talecris Biotherapeutics Holdings Corp. | a10-1548_1ex31d2.htm |
| EX-31.1 - EX-31.1 - Talecris Biotherapeutics Holdings Corp. | a10-1548_1ex31d1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-162999) of Talecris Biotherapeutics Holdings Corp. and its subsidiaries of our report dated February 23, 2010 relating to the financial statements and financial statement schedule, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
February 23, 2010